NCT03500289View on ClinicalTrials.gov

Ketamine for Treatment of MS Fatigue

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 10, 2018

Primary Completion Date

August 30, 2019

Study Completion Date

August 30, 2019

Conditions
Multiple SclerosisFatigue
Interventions
DRUG

Ketamine

One intravenous infusion of ketamine 0.5 mg/kg over 40 minutes

DRUG

Midazolam

One intravenous infusion of midazolam 0.05 mg/kg over 40 minutes

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

National Multiple Sclerosis Society

OTHER

lead

Johns Hopkins University

OTHER

NCT03500289 - Ketamine for Treatment of MS Fatigue | Biotech Hunter | Biotech Hunter